Green Synthetic Routes for Active Pharmaceutical Ingredients (APIs): A Comprehensive Review Recent Advances, Sustainable Methodologies, and Industrial Applications in Pharmaceutical Chemistry

Synthesizing pharmaceutical compounds demands exceptionally high structural precision, regio-selectivity, and absolute enantiomeric purity. Historically, reaching these target quality standards relied heavily on volatile organic solvents, heavy-metal catalysts, and multi-step protection strategies. Consequently, active pharmaceutical ingredient (API) production has generated disproportionately high Environmental Factors (E-factors, measured as kilograms of waste per kilogram of finalized drug product) compared to generic chemical sectors. Fundamental Paradigms: To resolve these sustainability hurdles, Anastas and Warner established foundational guidelines that prioritize waste elimination at the chemical design stage. Within active pharmaceutical synthesis, key priorities include:

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24333966
Primary Topic
Chemistry and Chemical Engineering
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Green Synthetic Routes for Active Pharmaceutical Ingredients (APIs): A Comprehensive Review Recent Advances, Sustainable Methodologies, and Industrial Applications in Pharmaceutical Chemistry

Maninder Kaur, Smita Patel, Sanjay Kumar Gautam, Prakash Sahu et al.
2 links
Zenodo (CERN European Organization for Nuclear Research)
Chemistry and Chemical Engineering
article

Green Synthetic Routes for Active Pharmaceutical Ingredients (APIs): A Comprehensive Review Recent Advances, Sustainable Methodologies, and Industrial Applications in Pharmaceutical Chemistry

Maninder Kaur, Smita Patel, Sanjay Kumar Gautam, Prakash Sahu, Govind Yadav, Varsha singh
article en

Abstract

Synthesizing pharmaceutical compounds demands exceptionally high structural precision, regio-selectivity, and absolute enantiomeric purity. Historically, reaching these target quality standards relied heavily on volatile organic solvents, heavy-metal catalysts, and multi-step protection strategies. Consequently, active pharmaceutical ingredient (API) production has generated disproportionately high Environmental Factors (E-factors, measured as kilograms of waste per kilogram of finalized drug product) compared to generic chemical sectors. Fundamental Paradigms: To resolve these sustainability hurdles, Anastas and Warner established foundational guidelines that prioritize waste elimination at the chemical design stage. Within active pharmaceutical synthesis, key priorities include:

Zenodo (CERN European Organization for Nuclear Research)
Responsible consumption and production
Chemistry and Chemical Engineering
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon